Comparative studies on cellular gene regulation by HIV-1 based vectors: implications for quality control of vector production.
Among the recent gene therapy protocols, vectors that can stably express transgenes, for example, HIV-1-based vectors, are particularly desirable. There have been no direct reports on insertional mutagenesis by lentiviral vectors; however, the severe pathogenic nature of their parental virus (HIV-1) is still a major safety concern surrounding these vectors and prevents the progress with their clinical application. We reason that by investigating the host response we shall be able to assess the safety and potential effects of the vectors on targeted cells and understand the interaction between vectors and the host. For this, two major sets of experiments were conducted. Initially, we used cDNA microarray methodology to examine cellular gene profile in human primary umbilical cord endothelial cells (HUVECs) after HIV-1-based VSV-G/GFP vector transduction and observed a modest effect of HIV-1-based vectors on HUVECs. The represented functional categories include transcription and translation factors, tumour antigens, complement factors and signal transduction factors. Some of the differentially expressed genes, for example, Clusterin, CD151, Ku antigen and eIF4gamma, could have oncogenic potential. In the second approach, we systematically compared five different viral vectors, that is, HIV-1-based VSV-G/Empty, VSV-G/GFP, VSV-G/puro, Amph/GFP and MLV-based Amph/Laz, for the effects of individual viral components on cellular gene regulation. Our comparative results demonstrated a regulatory function of Gag/Pol proteins on cellular gene expression. The significance of our findings in relation to the safety of HIV-1 vectors and the importance of quality control of vector production will be presented and discussed.
Zhao
Y
Y
Division of Immunobiology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK.
Azam
S
S
Thorpe
R
R
D015153:Blotting, Western / Q000379:methods; D042783:Endothelial Cells; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D015967:Gene Expression Regulation, Viral; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000009:adverse effects* / Q000235:genetics; D049452:Green Fluorescent Proteins / Q000235:genetics; D016655:HIV Core Protein p24 / Q000235:genetics*; D006801:Humans; D009052:Leukemia Virus, Murine / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012449:Safety; D014161:Transduction, Genetic / Q000379:methods
D016655:HIV Core Protein p24; D049452:Green Fluorescent Proteins